[1]
Camargo, M., Soto Marín, M.I., Zea, O. and Saavedra, D. 2008. Imatinib treatment and pharmacogenotype CYP3A4 in relation with the clonal expansion Ph(+) in chronic myeloid leukemia (CML). Colombia Medica. 39, 4 (Dec. 2008), 314–322. DOI:https://doi.org/10.25100/cm.v39i4.613.